2nd Targeting Therapy of Alzheimer’s and Related Neurodegenerative Diseases Virtual Conference

Organiser: Other


Attendance type(s): Virtual

Event Dates: 01—3 Nov 2021

  • 01/11/2021
  • 02/11/2021
  • 03/11/2021

Registration Deadline: 11 Oct 2021

Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, FTS and ALS affect over 5 million people in the US and over 35 million people worldwide. Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease and currently, only four drugs are approved for alleviating symptoms in AD patients, with no new therapies approved by FDA since 2003. Other related neurodegenerative diseases such as Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS) are also age-dependent and lack effective therapies. Hence, finding cures for AD and other related neurodegenerative diseases is urgent and various approaches should be actively pursued. This planned conference intends to bring leading scientists and clinicians from all over the world to present their unpublished observations or findings to attendees and to share their vision or prospects on translational research. We expect that some presenters, either by talks or posters, will discuss our current state of knowledge in disease mechanisms, novel targets, new genetic association or pathways, approaches for identifying new therapeutic targets, and biomarkers for diagnosis or treatment readouts. We will also invite speakers who are conducting later stages of drug discoveries to share clinical trial results. The talks and poster presentations will include the most updated therapeutic strategies, newly discovered therapeutic targets, and recent clinical developments at various stages in the area of Alzheimer’s and related neurodegenerative diseases.

Contact Details

Name: Fusion Conferences

Phone: 00441638724137

Email: admin@fusion-conferences.com

URL: https://online.fusion-conferences.com/